- Public StagePublicly traded company
- Top InvestorsThis company has received a significant amount of investment from top investors
- Website
- Location
- Company size
- 201-500 people
- Total raised
- $52.6M
- Company type
- Healthcare TechnologyBiotech
- Markets
PRENETICS careers
Founded in 2014, Prenetics is a major global diagnostics and genetic testing company with the mission to bring health closer to millions of people globally and decentralize healthcare by making the three pillars — Prevention, Diagnostics and Personalized Care — comprehensive and accessible to anyone, at anytime and anywhere.
Prenetics is led by visionary entrepreneur, Danny Yeung, with a team of over 700 employees and
operations across 9 locations, including United Kingdom, Hong Kong, India, South Africa, and Southeast Asia. Prenetics develops consumer genetic testing and early colorectal cancer screening; provides COVID19 testing, rapid point of care and at-home diagnostic testing and medical genetic testing.
Most recently, Prenetics made international headlines to become the first Unicorn in Hong Kong to publicly list on the Nasdaq via merger with 2021 Adrian Cheng's Artisan Acquisition Corp, valuing Prenetics at approximately US $1.7b.
Prenetics is led by visionary entrepreneur, Danny Yeung, with a team of over 700 employees and
operations across 9 locations, including United Kingdom, Hong Kong, India, South Africa, and Southeast Asia. Prenetics develops consumer genetic testing and early colorectal cancer screening; provides COVID19 testing, rapid point of care and at-home diagnostic testing and medical genetic testing.
Most recently, Prenetics made international headlines to become the first Unicorn in Hong Kong to publicly list on the Nasdaq via merger with 2021 Adrian Cheng's Artisan Acquisition Corp, valuing Prenetics at approximately US $1.7b.
PRENETICS hasn't added any jobs yet
Get notified when PRENETICS posts new jobs.
Professor Michael Yang
Ph.D. Toronto, Postdoc. Scripps, Chair Professor of Chemistry & Biomedical Sciences, City University of HK. Research: biochips, DNA diagnostics & nanomedicine.
Dr Lawrence Tzang
CEO of Prenetics, Founding Partner at SXE Ventures. Serial Entrepreneur, Investor, Mentor. Last start-up uBuyiBuy acquired by Groupon.
Total raised
$52.6M
Funded over
3 rounds
Latest round
Series B (Sep 2017)
BNY • Pittsburgh • 2 days ago
Moda Operandi • Brooklyn • 2 weeks ago
Tower Research Capital • Shanghai • 2 weeks ago
Elastic • United States • $133k – $211k • 4 weeks ago
Ontra • Remote • 4 weeks ago